
Language
Search
Product News
- Software Newsletter #37 - New TopSpin patch level 3 for version 2.1 now available
- Bruker Announces Order for 10 NMR Systems to Enable World-Class Scientific Research at King...
- Faster diagnoses thanks to new scanning technology
- Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
- Bruker BioSpin's MRI CryoProbe(TM) Selected for 2008 R&D 100 Award for Enabling Preclinical MRI on...
Pharmaceutical Reseach
Toxicology screening using NMR
The later that a molecule or molecular class is lost from the drug development pipeline, the higher the financial cost. Minimizing attrition is therefore one of the most important aims of a pharmaceutical discovery programme. Novel technologies that increase the probability of making the right choice early save resources, and promote safety, efficacy and profitability. Metabolomics is a systems approach for studying in vivo metabolic profiles, which promises to provide information on drug toxicity, disease processes and gene function at several stages in the discovery and-development process.

